Skip to main content

Diabetes & Weight Loss News

The new Look AHEAD trial analysis shows major heart and kidney benefits for type 2 diabetes patients in remission, reshaping views on lifestyle changes.
Explore the crucial link between diabetes and accelerated age-related muscle loss (sarcopenia), its impact on health, and strategies for managing muscle health in people...
2024 brings insulin price cuts but analysis shows 775 med price hikes, including diabetes drugs. Future price negotiations and affordability resources highlighted
The FDA is investigating reports of suicidal thoughts or actions in people taking diabetes and weight loss medications like Ozempic, Wegovy, and Mounjaro. Research is...
Explore weight management in children with diabetes with expert tips on healthy eating, regular exercise, and avoiding restrictive diets for overall health.
LillyDirect, a new telehealth platform and online pharmacy, aims to improve access to resources and medication for people living with diabetes, obesity, and migraines.
Polycystic ovarian syndrome (PCOS) affects millions, elevating the risk of type 2 diabetes due to hormonal imbalances and insulin resistance. Learn about its genetic...
Discover diaTribe's best 2023 diabetes articles on new treatments, advances in technology, lifestyle tips, and groundbreaking insights for better diabetes management.
Explore the emerging effects of GLP-1 receptor agonists on glycemic control and weight management, including their potential impact on birth control pill absorption and...
This article details Mounjaro's efficacy in type 2 diabetes management, highlighting the drug’s ability to significantly reduce A1C and body weight. Read about the...
People with diabetes are at higher risk for health issues like chronic kidney disease, diabetic macular edema, and liver disease. Here are clinical trials studying ways...
Orforglipron, Eli Lilly's once-daily oral GLP-1 receptor agonist, is being studied in ongoing clinical trials for obesity and type 2 diabetes. Data shows A1C reductions...
Explore the comprehensive diabetes support available to U.S. veterans. Here we highlight VHA benefits, the impact of obesity and mental health on diabetes risk, and...
FDA approves Zepbound for obesity management alongside diet and exercise. A promising new option for weight control, it's the second once-weekly injectable after Wegovy...
Explore the VITAL-CGM trial, which investigates if using a combination of CGM and WeightWatchers can lower A1C in people with type 2 diabetes.
Explore the link between obesity, diabetes, and breast cancer risk. Learn how treatments like bariatric surgery and medications can reduce this risk and aid in diabetes...
In case you missed them, here are our top stories from October 2023 that cover upcoming therapies, groundbreaking research, and more.
Lilly’s SURMOUNT-4 trial shows that Mounjaro (tirzepatide) offers remarkable weight loss in patients with a BMI of over 30. Full SURMOUNT-3 trial results highlighted the...
Data presented at EASD 2023 reveals orforglipron's potential in type 2 diabetes management. The new oral GLP-1 medication demonstrated significant reductions for A1C and...
Survodutide, a GLP-1/glucagon dual receptor agonist, shows promising weight loss results in a clinical trial. The injectable medication, developed by Zealand and...

Pages